While studying biochemistry as an undergraduate at the University of Southern California, he was a campus campaign coordinator for Teach for America and “recruited corps members and got people excited about closing the education gap across the United States!” During this time, he also co-founded a nonprofit, Project L, which provided art lessons in lower income elementary schools, and then sold the kids’ artwork to raise money for pediatric disease foundations. Additionally, during college, he worked as a research assistant for Children's Hospital Los Angeles, in General Pediatrics and the Emergency Department.
After college, Song received his master’s degree from Johns Hopkins, conducting research on optimizing gene delivery methods that could help brain tumor and cystic fibrosis patients. During this time, he also was a research assistant/volunteer for the Children's National Health System, where he was part of the PANDA team and pediatric palliative care special interest group “looking specifically at strategies to create a more quantifiable set of data for our patients.”
He then spent over a year as a post-graduate fellow at Yale in the lab of Mark Saltzman, PhD, Goizueta Foundation Professor of Biomedical Engineering. Song led efforts in synthesizing and characterizing various polymeric nanoparticles for direct delivery to the brain using convection-enhanced delivery.
Song applied to the MD-PhD program at Yale “because I saw how amazing the people at Yale were. Not only scientifically, or intellectually, but in how passionate they were about what they believed in, and how much they were willing to help you grow and find yourself as a person.”
In the MD-PhD program, Song is continuing work focused on brain tumors, but his research now includes an immunological perspective accompanying his engineering training. Working with his PhD mentor, Akiko Iwasaki, PhD, Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular and Developmental Biology, he identified a key limiting factor in invoking an immune response against brain tumors, which was published in Nature.
Iwasaki describes Song as "a very very special person." She continues, "he came to my lab before even starting the MD portion of his MD-PhD degree, and started working right away. He told me that he is very interested in finding a therapy for glioblastoma, a deadly form of brain cancer. He brought all necessary skills and knowledge to start a whole new program of brain tumor research in my lab. His first work, which showed that increasing lymphatic vessels in the meninges can promote immune response to brain tumor, was not only a groundbreaking scientific discovery, but also has an incredible implication for clinical treatment. Eric is also very savvy with the translation side of research. He is enabling translation of our research by creating alliance with biotech partners and clinical collaborators. I am so excited to see where Eric takes his science next!"
Song finds the most challenging part of research is that it takes a long time and “most times it does not go the way you imagined. But when you are able to fit the small mysteries together to complete a story, it refreshes you to continue going. And knowing that the progress you make will aid in helping patients one day is the most rewarding part about biomedical research.” He adds, “the intersection of science and medicine is unique in that it provides space for innovation and discovery with constant reminders of humanity and people. This makes it an exciting field to work in and motivates me daily.”
For Song, "the willingness to embrace the new, the strange, and the in need is distinctly” part of being a New American. He continues, “this means building off of, not only my past experiences, but my communities' hard work and effort in creating a space where new people from all backgrounds can join and feel welcomed. I will always live with this in mind and hope to accomplish work that will reflect the importance of people and community in creating a place for future generations of New Americans.”